Evidence map›Paper›PMID 30573459›Full record

ReviewAJNR. American journal of neuroradiology2019

High-Grade Gliomas in Children with Neurofibromatosis Type 1: Literature Review and Illustrative Cases.

C D Spyris, R C Castellino, M J Schniederjan, N Kadom

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in AJNR. American journal of neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Sustained response to trametinib in an adult patient with neurofibromatosis type 1 and high-grade glioma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  3. The Role of RAS in CNS Tumors: A Key Player or an Overlooked Oncogene?International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

C D SpyrisFrom the Departments of Radiology and Imaging Sciences (C.D.S., N.K.).ORCID 0000-0001-8467-8342
R C CastellinoPediatrics (R.C.C.).ORCID 0000-0002-3627-4850
M J SchniederjanPathology and Laboratory Medicine (M.J.S.), Emory University School of Medicine, Atlanta, Georgia.ORCID 0000-0003-4036-2316
N KadomFrom the Departments of Radiology and Imaging Sciences (C.D.S., N.K.) nkadom@emory.edu.ORCID 0000-0002-1591-9357
Emory University · USChildren's Healthcare of Atlanta · USNorwegian Womens Public Health Association · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-grade gliomas in patients with neurofibromatosis type 1 are rare and may therefore not be considered in the differential of brain lesions. Here, we describe 5 children with neurofibromatosis type 1; four of them developed various types of high-grade gliomas. The fifth patient had imaging features concerning for a high-grade lesion, but tissue diagnosis showed a low-grade glioma. The cases and literature summary provided here are to raise awareness for the occurrence of high-grade gliomas in children with neurofibromatosis type 1 and the limited ability of imaging features alone to predict a high-grade malignancy.

Indexed as

Brain NeoplasmsChildChild, PreschoolFemaleGliomaHumansMaleNeurofibromatosis 1

Identifiers

PMID30573459
PMCPMC7028622
OpenAlexW2905111826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.